M&A / Deals Ipsen to buy Swiss biotech Memo Therapeutics in potential $800M deal pharminent July 1, 2026
Pipeline AlzeCure enters collaboration agreement with QuantumCell ApS for NeuroRestore project pharminent July 1, 2026
Regulatory Eli Lilly and Regeneron among 7 companies picked for FDA PreCheck pilot program pharminent July 1, 2026
Clinical Data EAN 2026: Real-world data supports safety and efficacy of AbbVie’s Vyalev in Parkinson’s pharminent July 1, 2026
Regulatory Sarepta secures early 2027 FDA decision for Duchenne drugs, pushing past confirmatory fail pharminent July 1, 2026
News NEJM Retracts Pivotal Tavneos Paper as Amgen’s FDA Data-Integrity Fight Deepens pharminent June 30, 2026
Clinical Data Evommune ends development of lead asset in chronic hives after mid-stage efficacy woes pharminent June 30, 2026
News Viridian’s Lumvoa Wins FDA Approval, Taking Direct Aim at Amgen’s Tepezza in Thyroid Eye Disease pharminent June 29, 2026
Clinical Data BridgeBio’s achondroplasia pill shows ‘compelling’ growth and body proportionality benefit pharminent June 29, 2026
Regulatory Lilly’s Jaypirca receives CHMP positive opinion for CLL in Europe pharminent June 29, 2026
Regulatory Replimune gets early August decision date for twice-rejected melanoma drug pharminent June 26, 2026
Commercial Tryngolza charts blockbuster course after FDA’s hypertriglyceridemia approval pharminent June 26, 2026
M&A / Deals Ionis grants Recordati rights to zilganersen for Alexander disease pharminent June 26, 2026
News Merck KGaA to Acquire Bio-Techne for $11.3 Billion in Decade-Defining Life Sciences Bet pharminent June 25, 2026
Regulatory Ionis secures market expansion for Tryngolza as FDA clears severe hypertriglyceridemia use pharminent June 25, 2026
Regulatory FDA’s uniQure, REGENXBIO reversals could bolster other near-term rare disease applications pharminent June 25, 2026
Manufacturing SK pharmteco Launches SKyvec Viral Vector Platform for Gene Therapy pharminent June 24, 2026
News Novartis Strikes Up-to-$1.9 Billion Oncology Discovery Collaboration With Antares Therapeutics pharminent June 24, 2026
M&A / Deals URA and Lilly join forces to harmonise drug-wearable obesity care pharminent June 24, 2026
